SEARCH HEALTH CONDITIONS BY ALPHABETS
Short Stature for Age
Medications for Short Stature for Age
About Short Stature forage: Short stature describes to some person who`s considerably below the average height for an individual of the same age and sex -- specifically, the shortest 3 - 5 percent of the populace.
Drugs Used to Treat Short Stature for Age
The following listing of medications are in some way associated with, or found at the treating this illness.
Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
Genotropin | Rx | C | N | Insert review | 0.0 | ||
Generic title: somatropin systemic Drug category: Development hormones For consumers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
Omnitrope | Rx | C | N | 1 review | 10 | ||
Generic title: somatropin systemic Drug category: Development hormones For consumers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
Humatrope | Rx | C | N | 1 review | 10 | ||
Generic title: somatropin systemic Drug category: Development hormones For consumers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
Norditropin FlexPro | Rx | C | N | Insert review | 0.0 | ||
Generic title: somatropin systemic Drug category: Development hormones For consumers: dose, interactions, side effects | |||||||
somatropin | Rx | C | N | 3 reviews | 10 | ||
Generic title: somatropin systemic Brand titles: Genotropin, Omnitrope, Humatrope, Norditropin FlexPro, Norditropin, Saizen, Nutropin, Nutropin AQ, Zomacton...reveal all Drug category: Development hormones For consumers: dose, interactions, For professionals: a Z Drug Truth | |||||||
Norditropin | Rx | C | N | 1 review | 0.0 | ||
Generic title: somatropin systemic Drug category: Development hormones For consumers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
Saizen | Rx | C | N | Insert review | 0.0 | ||
Generic title: somatropin systemic Drug category: Development hormones For consumers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
Nutropin | Rx | C | N | Insert review | 0.0 | ||
Generic title: somatropin systemic Drug category: Development hormones For consumers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
Nutropin AQ | Rx | C | N | Insert review | 0.0 | ||
Generic title: somatropin systemic Drug category: Development hormones For consumers: dose, interactions, and side effects For professionals: Prescribing Information | |||||||
Zomacton | Rx | C | N | Insert review | 0.0 | ||
Generic title: somatropin systemic Drug category: Development hormones For consumers: dose, interactions, negative effects | |||||||
Legend
Rx | prescription-only |
---|---|
OTC | Over the Counter |
Rx/OTC | Prescription or Over the Counter |
Away Tag | This medication may well not be accepted by the FDA for treating this illness. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to present a risk to the fetus within the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women. |
C | Animal reproduction studies have demonstrated an adverse effect on the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with used in pregnant women clearly outweigh potential rewards. |
N | FDA has not classified this medication. |
Controlled Substances Act (CSA) Schedule | |
---|---|
N | Is not at the mercy of the Controlled Substances Act. |
1 | features a high possibility of abuse. Has no currently accepted medical use in treatment in the USA. There is a lack of accepted safety for use under medical supervision. |
2 | features a high possibility of abuse. Has a currently accepted medical use in treatment in the USA or a currently accepted medical use with severe restrictions. Psychotherapy can cause severe physical or psychological dependency. |
3 | features a possibility for abuse less than individuals in schedules 1 and 2 two. Has a currently accepted medical use in treatment in the USA. Psychotherapy can lead to physical dependence or high psychological dependence. |
4 | features a low potential for abuse relative to individuals in schedule 3. It has a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence relative to individuals in schedule 3. |
5 | features a low potential for abuse relative to individuals in schedule 4. Has a currently accepted medical use in treatment in the USA. Psychotherapy can lead to limited physical dependence or psychological dependence. |
Infection | |
---|---|
X | Interacts with Alcohol. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Frazee
- S
- T
- U
- V
- W
- X
- Y
- Z
Further information
Always seek advice from your physician to be sure the information displayed on these pages applies to your circumstances.